基于智能信息管理系统的门诊麻精药品全流程管理

doi:10.19803/j.1672-8629.20220176

中国药物警戒 ›› 2023, Vol. 20 ›› Issue (8): 899-903.
DOI: 10.19803/j.1672-8629.20220176

基于智能信息管理系统的门诊麻精药品全流程管理

史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚^*

郑州大学第一附属医院药学部,河南郑州 450052

收稿日期:2022-04-18 出版日期:2023-08-15 发布日期:2023-08-07
通讯作者: ^*张晓坚,男,主任药师,医院药事管理及临床药学。E-mail: zhxj0524@sina.com
作者简介:史香芬,女,硕士,副主任药师,医院药事管理。
基金资助:
国家科技重大专项新药创制(2020ZX09201-009); 河南省医学科技攻关计划软科学项目（RKX202202027）

Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system

SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian^*

Department of Pharmacy, First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan 450052, China

Received:2022-04-18 Online:2023-08-15 Published:2023-08-07

摘要/Abstract

摘要： 目的基于临床合理用药管理系统和医院信息管理系统规范门诊麻精药品处方审核与调剂流程。方法运用焦点管理循环模式（FOCUS-PDCA）循环法聚焦问题、发现问题、原因分析、对策拟定、实施改进措施,通过临床合理用药管理系统设置麻精药品适应证、用法用量、用药疗程等精细化审核规则;医师通过医院信息系统(HIS)中的电子病历系统建立癌症疼痛患者和中、重度慢性疼痛患者门诊病历,药师查询患者是否住院及历史处方取药间隔后调配处方。结果对8种麻醉和第一类精神药品、7种第二类精神药品分别设置精细化审核规则;门诊癌症疼痛患者和中、重度慢性疼痛患者均建立电子病历。门诊麻醉药品和第一类精神药品处方退费率由11.41%降低到2.32%,第二类精神药品处方合理率由86.81%提升至97.83%。结论通过精细化设置麻精药品处方审核规则、规范麻精药品处方调剂流程等措施实现了门诊麻精药品全流程管理,提高了门诊麻精药品处方合理率,确保了患者用药的合理性和安全性。

关键词: 麻醉药品, 精神药品, 临床合理用药管理系统, 医院信息系统, PDCA, 处方合理率

Abstract: Objective To standardize the prescription review and dispensing process of outpatient anesthetics based on the clinical rational drug use management system and hospital information system. Methods The FOCUS-PDCA method was used to identify problems, analyze the causes, formulate and implement interventions. The management system for clinical rational drug use was used to set up detailed audit rules for the indications, usage and dosage and courses of treatment. Pharmacists established medical records of outpatients with cancer pain via the electronic medical record system in the hospital information system (HIS). They also adjusted prescriptions after finding out whether an outpatient was hospitalized and when previous drugs were dispensed with. Results According to drug instructions and related laws and regulations, detailed audit rules were formulated for 8 categories of narcotic drugs and class I psychotropic drugs and for 7 categories of class II psychotropic drugs. Electronic medical records of outpatients were established for cancer patients. The refund rate of outpatient prescriptions for narcotic drugs and class I psychotropic drugs decreased from 11.41% to 2.32%, and the rate of standard use of class II psychotropic drugs increased from 86.81% to 97.83%. Conclusion The whole process management of narcotic drugs and psychotropic drugs for outpatients can improve the rate of standard prescriptions, and ensure the rationality and safety of patients' medication.

Key words: narcotic drugs, psychotropic drugs, management system for clinical rational drug use, hospital information system, PDCA, rate of rational prescriptions

中图分类号:

R994.11

史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.

SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian. Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.

参考文献

[1] NHCPRC. Information[EB/OL]. [2023-02-16]. http://www.nhc.gov,cn/wjw/xinx/xinxi.shtml.
[2] MAN CX, ZHOU WJ, YANG SP, et al.Study on narcotics and psychotropic substances control (part X): comparative study on domestic and foreign control system of narcotics and psychotropic substances[J]. Ching Pharmacy(中国药房), 2017, 28(1):23-26.
[3] FAN YY, QI YY, MU XJ, et al.Suggestions on improvement of administrative regulations on narcotic drugs and psychotropic drugs in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(1): 28-31.
[4] XIE DR, YANG HP, ZHU LR, et al.Problems and solutions of the enforcement of usage regulation on narcotic drugs and psychotropic substances in medical institutions[J]. China Pharmacy(中国药房), 2013, 24(25): 2397-2400.
[5] LU XJ, SHI XF, ZHANG XF, et al.Analysis of narcotics drugs use among outpatients at a hospital: based on individual data[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2021, 41(10): 1049-1053.
[6] National Health Commission of the People's Republic of China. Notice on strengthening the control of narcotic drugs and category I psychotropic drugs in medical institutions[EB/OL]. (2020-09-15)[2023-02-16].http://www.nhc.gov.cn/yzygj/s7659/202009/ee4a21c2756f440e98f78d2533d7539a.shtml.
[7] LIU R, GU BA QN, ZHU Q.Application of focal-PDCA in reducing error rate of pharmacy allocation[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2020, 40(24) :2595-2599, 2610.
[8] SHI HL, CHEN D, HUANG LX.Department of anesthesiology, psychotropic drugs of category I used in the refined management of drug circulation of FOCUS-PDCA in our hospital[J]. Chinese Journal of Rational Drug Use(中国合理用药探索), 2017, 14(1): 31-33,41.
[9] SHI XF, SUN ZY, WANG XY, et al.Application of quality control circle in the management of drug repercussion in outpatient pharmacy of our hospital[J]. Ching Pharmacy(中国药房), 2018, 29(1): 25-28.
[10] JIAO Y, SONG YX, ZHANG J, et al.Discussion on using quality control circle to improve the qualified rate of anesthesia prescription in our hospital[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2020, 55(11): 951-954.
[11] ZENG HL, ZHU YC.Application of quality control circle in improving prescription qualification rate of narcotic drugs and category I psychotropic drugs in our hospital[J]. Strait Pharmaceutical Journal(海峡药学), 2019, 31(9): 284-285.
[12] WANG MK, SUN XH.Outpatient pharmacy intervention to promote rational use of narcotic and psychotropic drugs prescription[J].Shenzhen Journal of Integrated Traditional Chinese and Western Medical(深圳中西医结合杂志), 2020, 30(24): 103-104.
[13] LI GS, WU MX.Application of PDCA cycle method in standard management and use of anesthetic drugs in our hospital[J]. Strait Pharmaceutical Journal(海峡药学), 2020, 32(2): 171-173.
[14] VAN DBEMHJ, VAN KSMJ, JANSSEN DJA, et al.Treatment of pain in cancer: towards personalised medicine[J]. Cancers (Basel), 2018, 10(12): 502.
[15] ZHANG XF, SHI XF, LU XJ, et al.Fine setting and implementation effect evaluation of the use rules for narcotic drugs and psychotropic drugs based on outpatient prescription pre-review system[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2022, 42(9): 935-939.
[16] ZUO J, LI X, LIAO LN, et al.Analysis of implementation of pre-prescription review system in our hospital[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(22): 2338-2341.
[17] ZHANG XF, SHI XF, LU XJ, et al.Practice of outpatient prescription review based on clinical rational drug use intelligent management system[J]. Herald of Medicine(医药导报), 2021, 40(6): 837-841.
[18] XING XY, ZHANG H, CHAO H, et al.Closed-loop management of narcotic and psychotropic drugs based on HIS system[J]. Perioperative Safety and Quality Assurance(麻醉安全与质控) , 2021, 5(2): 97-99.
[19] LIU D, LI GH, ZHAO RS, et al.Expert consensus on information management of narcotic drugs and class I psychotropic substances in medical institutions[J]. Herald of Medicine(医药导报), 2022, 41(1): 1-7.

基于智能信息管理系统的门诊麻精药品全流程管理

Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	苏鑫鑫, 赵晓晓, 谢雁鸣. 榄香烯乳注射液治疗肝癌患者的真实世界联合用药分析[J]. 中国药物警戒, 2022, 19(9): 929-934.
[2]	黄艳丽, 谢雁鸣, 王连心, 孙粼希, 刘峘, 庄鋆妮. 真实世界老年患者使用刺五加注射液的临床分析[J]. 中国药物警戒, 2022, 19(9): 935-939.
[3]	刘斌, 邵美玲, 蔡怡然, 马丰懿, 兰鸿. 戴明环循环管理在提高门诊处方合理率中的应用价值[J]. 中国药物警戒, 2022, 19(9): 1035-1039.
[4]	刘斌, 吕家麟, 尹若云, 周鹃, 黄河浪, 吴磊. 吸毒人员医用麻精药品滥用风险研究[J]. 中国药物警戒, 2020, 17(11): 828-832.
[5]	郭飞, 李涛, 孙瑞洁, 牛慧芳, 黄云慧, 陈永新, 王金宝, 张瑞岭. 某精神专科医院药学干预对二类精神药品使用的影响[J]. 中国药物警戒, 2019, 16(9): 550-554.
[6]	白丽琴, 王军. 云南省10家医院艾司唑仑片使用情况分析[J]. 中国药物警戒, 2019, 16(12): 734-740.
[7]	樊莹莹, 齐莹莹, 穆星佳, 王晨慧, 姜庆丹, 乔明娟. 我国麻醉药品和精神药品行政监管法规完善建议[J]. 中国药物警戒, 2018, 15(1): 28-31.
[8]	余超,徐玉茗,李馨龄,王玲,周鹃,万凯化,徐瑾,袁兴东. 我国医院信息系统与国家药品不良反应监测系统对接的需求调研[J]. 中国药物警戒, 2016, 13(3): 154-158.
[9]	王亚丽, 张倩婷, 苑国辉, 王力剑, 曲毅. 1188例苯二氮卓类药物滥用监测数据分析[J]. 中国药物警戒, 2016, 13(10): 614-618.
[10]	韦宁, 盘红梅, 廖艺. 基于PDCA循环的病区麻醉药品、第一类精神药品管理研究[J]. 中国药物警戒, 2015, 12(8): 500-502.
[11]	王玲. 基于医院信息系统开展药品不良反应监测研究[J]. 中国药物警戒, 2015, 12(4): 229-231.
[12]	王玲. 欧美药物警戒中电子化医疗保健数据的应用研究[J]. 中国药物警戒, 2015, 12(3): 156-159.
[13]	邓剑雄, 王玲, 陈文戈, 舒婷, 张业象. 基于HIS的药品不良反应快速上报与智能搜索系统研究与应用[J]. 中国药物警戒, 2015, 12(12): 731-734.
[14]	王玲. 试论医疗大数据给药品安全性监测与评价带来的机遇和挑战[J]. 中国药物警戒, 2015, 12(11): 660-664.
[15]	左拥军,李永兵. 我院2011～2012年门诊癌症患者麻醉药品使用分析[J]. 中国药物警戒, 2013, 10(7): 419-420.